Blueline Advisors’s Johnson & Johnson JNJ Stock Holding History

Blueline Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.5K	Hold	120	–	–	0.02%	125
2026 Q1	$29.3K	Hold	120	–	–	0.02%	113
2025 Q4	$24.8K	Buy	+120	New	+$23.7K	0.02%	109

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Blueline Advisors's JNJ Position: Q2 2026 in Review

Blueline Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 120 shares worth $30.5K. The position accounts for 0.02% of the portfolio, ranked #125.

Blueline Advisors first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Blueline Advisors held 120 shares of Johnson & Johnson worth $30.5K as of Q2 2026.
Blueline Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 0.02% of Blueline Advisors's portfolio in Q2 2026, its #125 holding.
Blueline Advisors first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Blueline Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.